Role Summary Our protease inhibitor, oral PAXLOVID, has been developed at light-speed . On May 25, 2023, the U.S. Food and Drug Administration (FDA) approved PAXLOVID for...
Read More
Role Summary Our protease inhibitor, oral PAXLOVID, has been developed at light-speed . On May 25, 2023, the U.S. Food and Drug...
Read More